BusinessAnt International powers Iraqi fintech digital platform by The Tamesis SuperQi combines Western banking models with Asian super app practices to offer scan-to-pay, transfer and more. Post Views: 82 Share this Facebook X Telegram Whatsapp Email TagsAntDigitalfintechINTERNATIONALIraqiplatformpowersRelated Posts Pakistan’s Novacare, SSI companion on electronic healthcare facility task September 26, 2025 Peak XV Bank On AI, Fintech And Customer Startups September 25, 2025 Peak XV Bank On AI, Fintech And Sports Apparel Startups September 25, 2025 The TamesisLeave a Reply Cancel replyYour email address will not be published. Save my name, email, and website in this browser for the next time I comment. Previous StoryPresident Yoon Suk Yeol defiant, vows to fight arrest ‘until the end’ Next StoryBillionaire Li Ka-Shing’s Drug Maker Hutchmed Sells $608 Million Stake In Cardiovascular Joint Venture Latest from Blog Giuseppe di Morabito Springtime 2026 Ready-to-Wear Collection by The Tamesis Leonardo DiCaprio on Sanctuary Performance With Paul McCartney: ‘Extraordinary’ by The Tamesis David Zwirner Labels Ebony L. Haynes Global Head of Curatorial Projects by The Tamesis Zara Larsson on Her Certain (and At Risk) New Document by The Tamesis Brioni Springtime 2026 Ready-to-Wear Collection by The Tamesis Finest Brand-new Songs of the Week Survey by The Tamesis Versace Springtime 2026 Ready-to-Wear by The Tamesis Court Denies Ronald Perelman’s $400 M. Art Insurance Policy Insurance Claim by The Tamesis 50+ Ideal Black Boots for Female This Autumn & Wintertime 2025 by The Tamesis 20 Emphasizes From the 2025 New York City Movie Event by The TamesisRelated Posts Pakistan’s Novacare, SSI companion on electronic healthcare facility task September 26, 2025 Peak XV Bank On AI, Fintech And Customer Startups September 25, 2025 Peak XV Bank On AI, Fintech And Sports Apparel Startups September 25, 2025 Previous StoryPresident Yoon Suk Yeol defiant, vows to fight arrest ‘until the end’ Next StoryBillionaire Li Ka-Shing’s Drug Maker Hutchmed Sells $608 Million Stake In Cardiovascular Joint Venture